192 related articles for article (PubMed ID: 26191083)
1. Altering cancer transcriptomes using epigenomic inhibitors.
Gaddis M; Gerrard D; Frietze S; Farnham PJ
Epigenetics Chromatin; 2015; 8():9. PubMed ID: 26191083
[TBL] [Abstract][Full Text] [Related]
2. Determination of the Role of CBP- and p300-Mediated Wnt Signaling on Colonic Cells.
Bordonaro M; Lazarova DL
JMIR Res Protoc; 2016 May; 5(2):e66. PubMed ID: 27177606
[TBL] [Abstract][Full Text] [Related]
3. Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia.
Gang EJ; Hsieh YT; Pham J; Zhao Y; Nguyen C; Huantes S; Park E; Naing K; Klemm L; Swaminathan S; Conway EM; Pelus LM; Crispino J; Mullighan CG; McMillan M; Müschen M; Kahn M; Kim YM
Oncogene; 2014 Apr; 33(17):2169-78. PubMed ID: 23728349
[TBL] [Abstract][Full Text] [Related]
4. The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner.
Wiese M; Walther N; Diederichs C; Schill F; Monecke S; Salinas G; Sturm D; Pfister SM; Dressel R; Johnsen SA; Kramm CM
Oncotarget; 2017 Apr; 8(16):27300-27313. PubMed ID: 28460484
[TBL] [Abstract][Full Text] [Related]
5. Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and beta-catenin.
Labalette C; Renard CA; Neuveut C; Buendia MA; Wei Y
Mol Cell Biol; 2004 Dec; 24(24):10689-702. PubMed ID: 15572674
[TBL] [Abstract][Full Text] [Related]
6. Hypothesis: Sam68 and Pygo2 mediate cell type-specific effects of the modulation of CBP-Wnt and p300-Wnt activities in Colorectal Cancer Cells.
Bordonaro M
J Cancer; 2021; 12(16):5046-5052. PubMed ID: 34234873
[TBL] [Abstract][Full Text] [Related]
7. Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression.
Ma H; Nguyen C; Lee KS; Kahn M
Oncogene; 2005 May; 24(22):3619-31. PubMed ID: 15782138
[TBL] [Abstract][Full Text] [Related]
8. DIF-1 inhibits the Wnt/β-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines.
Jingushi K; Takahashi-Yanaga F; Yoshihara T; Shiraishi F; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
Biochem Pharmacol; 2012 Jan; 83(1):47-56. PubMed ID: 22005519
[TBL] [Abstract][Full Text] [Related]
9. Rac1 GTPase and the Rac1 exchange factor Tiam1 associate with Wnt-responsive promoters to enhance beta-catenin/TCF-dependent transcription in colorectal cancer cells.
Buongiorno P; Pethe VV; Charames GS; Esufali S; Bapat B
Mol Cancer; 2008 Sep; 7():73. PubMed ID: 18826597
[TBL] [Abstract][Full Text] [Related]
10. CBP Activity Mediates Effects of the Histone Deacetylase Inhibitor Butyrate on WNT Activity and Apoptosis in Colon Cancer Cells.
Lazarova DL; Chiaro C; Wong T; Drago E; Rainey A; O'Malley S; Bordonaro M
J Cancer; 2013; 4(6):481-90. PubMed ID: 23901348
[TBL] [Abstract][Full Text] [Related]
11. CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer.
Bordonaro M; Lazarova DL
World J Gastroenterol; 2015 Jul; 21(27):8238-48. PubMed ID: 26217075
[TBL] [Abstract][Full Text] [Related]
12. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
Esufali S; Bapat B
Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
[TBL] [Abstract][Full Text] [Related]
13. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
14. WNT/β-catenin signaling inhibits CBP-mediated RelA acetylation and expression of proinflammatory NF-κB target genes.
Ma B; Fey M; Hottiger MO
J Cell Sci; 2015 Jul; 128(14):2430-6. PubMed ID: 26021349
[TBL] [Abstract][Full Text] [Related]
15. Wnt/β-catenin signaling mediates the antitumor activity of magnolol in colorectal cancer cells.
Kang YJ; Park HJ; Chung HJ; Min HY; Park EJ; Lee MA; Shin Y; Lee SK
Mol Pharmacol; 2012 Aug; 82(2):168-77. PubMed ID: 22550094
[TBL] [Abstract][Full Text] [Related]
16. p300 Influences Butyrate-Mediated WNT Hyperactivation In Colorectal Cancer Cells.
Lazarova DL; Wong T; Chiaro C; Drago E; Bordonaro M
J Cancer; 2013; 4(6):491-501. PubMed ID: 23901349
[TBL] [Abstract][Full Text] [Related]
17. Involvement of activator protein-1 family members in β-catenin and p300 association on the genome of PANC-1 cells.
Doi T; Hojo H; Ohba S; Obayashi K; Endo M; Ishizaki T; Katoh A; Kouji H
Heliyon; 2022 Feb; 8(2):e08890. PubMed ID: 35198763
[TBL] [Abstract][Full Text] [Related]
18. Activation of the canonical WNT signaling pathway promotes ovarian surface epithelial proliferation without inducing β-catenin/Tcf-mediated reporter expression.
Usongo M; Li X; Farookhi R
Dev Dyn; 2013 Mar; 242(3):291-300. PubMed ID: 23239518
[TBL] [Abstract][Full Text] [Related]
19. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
20. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer.
González-Sancho JM; Aguilera O; García JM; Pendás-Franco N; Peña C; Cal S; García de Herreros A; Bonilla F; Muñoz A
Oncogene; 2005 Feb; 24(6):1098-103. PubMed ID: 15592505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]